Issue 19, 2014

Conjugation of vitamin E analog α-TOS to Pt(iv) complexes for dual-targeting anticancer therapy

Abstract

We report two platinum(IV) complexes conjugated with a vitamin E analog, α-tocopherol succinate (α-TOS). One of the conjugates displays the activity of both cisplatin and α-TOS in cancer cells, causing damage to DNA and mitochondria simultaneously. Accordingly, it serves as a promising dual-targeting anticancer agent.

Graphical abstract: Conjugation of vitamin E analog α-TOS to Pt(iv) complexes for dual-targeting anticancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
15 Nov 2013
Accepted
10 Dec 2013
First published
11 Dec 2013

Chem. Commun., 2014,50, 2465-2468

Conjugation of vitamin E analog α-TOS to Pt(IV) complexes for dual-targeting anticancer therapy

K. Suntharalingam, Y. Song and S. J. Lippard, Chem. Commun., 2014, 50, 2465 DOI: 10.1039/C3CC48740G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements